Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 44 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Pediatrix Clear all

Conditions: Neonatal Abstinence Syndrome, Neonatal Withdrawal Syndrome
Interventions: Buprenorphine, Morphine Sulfate; Drug
Lead sponsor: Pediatrix; Other
Eligibility: Up to 1 Year
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Congenital Heart Disease
Interventions: Not listed
Lead sponsor: Pediatrix; Other
Eligibility: Up to 30 Days
Enrollment: 6,147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Trenton, New Jersey

Conditions: Maternal; Chorioamnionitis, Affecting Fetus, Early-Onset Sepses, Neonatal
Interventions: EOS Calculator; Diagnostic Test
Lead sponsor: Pediatrix; Other
Eligibility: 35 Weeks and older
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Preterm Delivery
Interventions: Not listed
Lead sponsor: Obstetrix Medical Group; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 995 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 10
States / cities: Mesa, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 7 more

Conditions: Sickle Cell Anemia
Interventions: Voxelotor; Drug
Lead sponsor: Elizabeth Yang, MD, PhD; Other
Eligibility: 12 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Hypoglycemia, Neonatal Hypoglycemia
Interventions: Not listed
Lead sponsor: Pediatrix; Other
Eligibility: 34 Weeks and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Neonatal Mortality
Interventions: Not listed
Lead sponsor: Pediatrix; Other
Eligibility: 22 Weeks to 44 Weeks
Enrollment: 645 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Anchorage, Alaska

Conditions: Apnea of Prematurity
Interventions: Not listed
Lead sponsor: Pediatrix; Other
Eligibility: 23 Weeks to 29 Weeks
Enrollment: 160 participants
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Labor Induction
Interventions: CERVIDIL (Dinoprostone), FOLEY BALLOON; Drug · Device
Lead sponsor: Pediatrix; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 376 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Mesa, Arizona • Phoenix, Arizona

Conditions: Sensorineural Hearing Loss, Long QT Syndrome
Interventions: Not listed
Lead sponsor: Pediatrix; Other
Eligibility: 1 Day to 90 Days
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 12
States / cities: Anchorage, Alaska • Phoenix, Arizona • Waterford, Connecticut + 6 more

Conditions: Vasa Previa
Interventions: Not listed
Lead sponsor: Obstetrix Medical Group; Industry
Eligibility: Female only
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 9
States / cities: Mobile, Alabama • Mesa, Arizona • Phoenix, Arizona + 6 more

Conditions: Placenta Previa
Interventions: Cervical Pessary Placement; Procedure
Lead sponsor: Pediatrix; Other
Eligibility: 18 Years to 54 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 10
States / cities: Mobile, Alabama • Long Beach, California • San Jose, California + 6 more

Conditions: Hyperbilirubinemia, Jaundice
Interventions: Gene mutation sample; Procedure
Lead sponsor: Pediatrix; Other
Eligibility: Up to 6 Days
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Bacterial Contamination Rate of the Cell Phones
Interventions: Not listed
Lead sponsor: Pediatrix; Other
Eligibility: 13 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Human Milk/Breastfeeding
Interventions: Human Milk; Dietary Supplement
Lead sponsor: Pediatrix; Other
Eligibility: Not listed
Enrollment: 1,160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 5
States / cities: Scottsdale, Arizona • Las Vegas, Nevada • Dallas, Texas + 2 more

Conditions: Malnutrition
Interventions: Parenteral Nutrition; Drug
Lead sponsor: Pediatrix; Other
Eligibility: 0 Years to 48 Hours
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Florence, South Carolina

Conditions: Prematurity, Nutrition
Interventions: Not listed
Lead sponsor: Pediatrix; Other
Eligibility: 23 Weeks to 30 Weeks
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Chorioamnionitis
Interventions: Retrospective Chart Review; Other
Lead sponsor: Pediatrix; Other
Eligibility: 35 Weeks to 42 Weeks · Female only
Enrollment: 768 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Greensboro, North Carolina

Conditions: Knee Replacement Surgery
Interventions: Nasal Continuous Positive Airway Pressure (NCPAP); Other
Lead sponsor: Pediatrix; Other
Eligibility: 21 Years to 69 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Patent Ductus Arteriosus
Interventions: Not listed
Lead sponsor: Pediatrix; Other
Eligibility: 22 Weeks to 32 Weeks
Enrollment: 208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 16
States / cities: Anchorage, Alaska • Phoenix, Arizona • Tucson, Arizona + 11 more

Conditions: Total Parenteral Nutrition-induced Cholestasis
Interventions: Omegaven, Omegaven; Dietary Supplement · Drug
Lead sponsor: Pediatrix; Other
Eligibility: 14 Days to 2 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Diabetes, Gestational Diabetes, Diabetes Mellitus, Type 2
Interventions: 2 hour glucose tolerance test using 75g glucose drink; Diagnostic Test
Lead sponsor: Pediatrix; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Fetal Membranes, Premature Rupture
Interventions: Retention of Cerclage, Removal of Cerclage, Removal vs. Retention of Cervical Cerclage; Procedure
Lead sponsor: Obstetrix Medical Group; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 23
States / cities: Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 18 more

Conditions: Preterm Delivery
Interventions: 17-alpha-hydroxy-progesterone caproate, Makena®, Castor Oil (Placebo); Drug
Lead sponsor: Obstetrix Medical Group; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 15
States / cities: Mobile, Alabama • Mesa, Arizona • Phoenix, Arizona + 10 more

Search by objective public record fields.

Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)

The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease

A Chart Review of Newborns With the Presence of Confirmed or Suspected Maternal Chorioamnionitis and Utilization of the Early Onset Sepsis Calculator

Neonatal Outcome by Reason for Delivery

Voxelotor Sickle Cell Exercise Study

Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission

Factors Associated With Mortality in Neonates

The Effect of Standardizing the Definition of a Clinically Significant Cardiopulmonary Event on Length of Stay

Foley Catheter Versus Cervidil for Induction of Labor at Term

Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss.

Optimal Management of Vasa Previa Study - A Retrospective Study

Vaginal Pessary Versus Expectant Management for Placenta Previa

Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia

Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU

Human Milk Feeding Rates Post-NICU Discharge

Dose Comparison of Amino Acids on Growth in Premature Neonates

Nutritional Content of Breast Milk From Mothers of Premies

Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis

The Effect of Nasal Continuous Positive Airway Pressure (N-CPAP) on Arterial pCO2 During Spinal Anesthesia

PDA Post NICU Discharge

Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants

GDM Post Partum Screening

Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)

Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM)